These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8389449)

  • 1. Changing Epstein-Barr viral ZEBRA protein into a more powerful activator enhances its capacity to disrupt latency.
    Baumann R; Grogan E; Ptashne M; Miller G
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4436-40. PubMed ID: 8389449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency.
    Francis AL; Gradoville L; Miller G
    J Virol; 1997 Apr; 71(4):3054-61. PubMed ID: 9060666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
    Francis A; Ragoczy T; Gradoville L; Heston L; El-Guindy A; Endo Y; Miller G
    J Virol; 1999 Jun; 73(6):4543-51. PubMed ID: 10233912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of the Epstein-Barr virus ZEBRA protein's capacity to disrupt latency by the addition of heterologous activation regions.
    Baumann R; Warren G; Askovic S
    Virology; 1995 Aug; 211(1):64-72. PubMed ID: 7645237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
    Kolman JL; Taylor N; Gradoville L; Countryman J; Miller G
    J Virol; 1996 Mar; 70(3):1493-504. PubMed ID: 8627667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site.
    Zetterberg H; Jansson A; Rymo L; Chen F; Karlsson A; Klein G; Brodin B
    J Gen Virol; 2002 Aug; 83(Pt 8):2007-2014. PubMed ID: 12124465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation domain requirements for disruption of Epstein-Barr virus latency by ZEBRA.
    Asković S; Baumann R
    J Virol; 1997 Sep; 71(9):6547-54. PubMed ID: 9261375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The position of the ZEBRA activation domain does not influence its biological activity.
    Asković S; Taylor W; Baumann R
    Virus Res; 1998 Oct; 57(2):125-38. PubMed ID: 9870581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.
    Carey M; Kolman J; Katz DA; Gradoville L; Barberis L; Miller G
    J Virol; 1992 Aug; 66(8):4803-13. PubMed ID: 1321270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.
    Heston L; El-Guindy A; Countryman J; Dela Cruz C; Delecluse HJ; Miller G
    J Virol; 2006 Sep; 80(18):9115-33. PubMed ID: 16940523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.
    El-Guindy AS; Miller G
    J Virol; 2004 Jul; 78(14):7634-44. PubMed ID: 15220438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
    Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
    J Virol; 2017 May; 91(9):. PubMed ID: 28228591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoacceptor site S173 in the regulatory domain of Epstein-Barr Virus ZEBRA protein is required for lytic DNA replication but not for activation of viral early genes.
    El-Guindy A; Heston L; Delecluse HJ; Miller G
    J Virol; 2007 Apr; 81(7):3303-16. PubMed ID: 17215287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Epstein-Barr virus BMRF1 and BZLF1 promoters by ZEBRA in Saccharomyces cerevisiae.
    Countryman JK; Heston L; Gradoville L; Himmelfarb H; Serdy S; Miller G
    J Virol; 1994 Nov; 68(11):7628-33. PubMed ID: 7933154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis.
    Serio TR; Kolman JL; Miller G
    J Virol; 1997 Nov; 71(11):8726-34. PubMed ID: 9343231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subset of replication proteins enhances origin recognition and lytic replication by the Epstein-Barr virus ZEBRA protein.
    El-Guindy A; Heston L; Miller G
    PLoS Pathog; 2010 Aug; 6(8):e1001054. PubMed ID: 20808903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing regions of the Epstein-Barr virus ZEBRA protein which function as transcriptional activating sequences in Saccharomyces cerevisiae and in B cells.
    Miller G; Himmelfarb H; Heston L; Countryman J; Gradoville L; Baumann R; Chi T; Carey M
    J Virol; 1993 Dec; 67(12):7472-81. PubMed ID: 8230468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.